Adding Toripalimab to Chemotherapy Improves Survival in Advanced NSCLC

Adding toripalimab to first-line chemotherapy improves overall survival in patients with advanced non-small cell lung cancer.

Related Keywords

Changsha , Hunan , China , Jiangsu , Shanghai , Lin Wu , Junshi Biosciences , , Hunan Cancer Hospital , Shanghai Junshi ,